跳至主要内容
临床试验/CTRI/2023/06/054425
CTRI/2023/06/054425已完成Unknown

A prospective, single arm, open label, single centre clinical study to evaluate the safety and efficacy of Nimson Almond oil in Dandruff and Hairfall control

Aryanveda Cosmeceuticals1 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2023年4月7日最近更新:

试验速览

阶段
Unknown
状态
已完成
发起方
入组人数
30
试验地点
1
主要终点
• Excellent reduction in the shedding range of the hair in the “60 Second Hair Comb testâ€

研究概览

简要总结

This study is a prospective, single arm, open label, single centre clinical study to evaluate the safety and efficacy of Nimson Almond oil in Dandruff and Hairfall control.

. Primary Objective

• Reduction in the hair fall from Visit 1 to the end of the study.

• Reduction in the dandruff flakes and itching of the scalp.

Secondary Objective

• Improvement in the subjective hair assessment questionnaire.

• Improvement in the IP feedback questionnaire from visit 2 to end of the study

研究设计

研究类型
Observational

入排标准

年龄范围
18.00 Year(s) 至 65.00 Year(s)(—)
性别
All

入选标准

  • Subjects aged between 18 to 65 years.
  • Subjects who willing to give written informed consent and ready to comply with the protocol.
  • Subjects with active alopecia, seborrheic dermatitis of the scalp – “Total ASFS Score ≥ 16
  • Subjects with a minimum hair length of 2 inches and willing to maintain the same minimum length, hair style until the end of the study.

排除标准

  • Subjects on topical treatment for alopecia and seborrheic dermatitis for 8 weeks prior to enrollment.
  • Subject with other dermatological disorders of the scalp that might interfere with the study evaluation.
  • Subjects with significant scalp scarring.
  • Subjects who have anemia or iron deficiency.
  • Subjects who have previously undergone hair transplantation procedures.
  • History of systemic or cutaneous malignancy or evidence of immunocompromised state.
  • Subjects with history of skin allergy.
  • Subjects on systemic steroids for more than 14 days within 2 months prior to enrollment.
  • Female subjects who are reported pregnant/planning a pregnancy or lactating.
  • Subjects who are currently enrolled in an active investigational study or have participated in an investigational study within 30 days prior to enrollment.
  • Subjects, who in the opinion of the Investigator or the Expert Dermatologist are not eligible for enrollment in the study.

结局指标

主要结局

• Excellent reduction in the shedding range of the hair in the “60 Second Hair Comb testâ€

时间窗: Day 42

from Visit 1 to the end of the study.

时间窗: Day 42

• Excellent reduction in the flaking severity in the “Adherent Scalp Flaking Score†from Visit 1 to the end of the study.

时间窗: Day 42

• Excellent reduction of dandruff & itching of scalp.

时间窗: Day 42

次要结局

  • • Reasonable improvement in the “Subjective Hair Assessment Questionnaire†score from visit 1 to end of the study.(• Reasonable improvement in the “Subject IP Feedback Questionnaire†score from Visit 2 to end of study.)

研究者

发起方
Aryanveda Cosmeceuticals
申办方类型
Pharmaceutical industry-Indian

研究点 (1)

Loading locations...

相似试验